FDA Approved Products

553 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: Pre-LaunchClear all
DIASONE SODIUM
sulfoxone sodium
Pre-Launch
AbbVie
ORAL · TABLET, DELAYED RELEASE
NDA
DICUMAROL
dicumarol
Pre-Launch
Eli Lilly and Company
ORAL · CAPSULE
NDA
DICURIN PROCAINE
procaine merethoxylline; theophylline
Pre-Launch
Eli Lilly and Company
INJECTION · INJECTABLE
NDA
DIETHYLSTILBESTROL
diethylstilbestrol
Pre-Launch
Eli Lilly and Company
ORAL · TABLET, DELAYED RELEASE
NDA
DIETHYLSTILBESTROL
diethylstilbestrol
Pre-Launch
Eli Lilly and Company
ORAL · TABLET
NDA
DIETHYLSTILBESTROL
diethylstilbestrol
Pre-Launch
Eli Lilly and Company
VAGINAL · SUPPOSITORY
NDA
DIONOSIL AQUEOUS
propyliodone
Pre-Launch
GSK
INTRATRACHEAL · SUSPENSION
NDA
DIONOSIL OILY
propyliodone
Pre-Launch
GSK
INTRATRACHEAL · SUSPENSION
NDA
DIPROSONE
betamethasone dipropionate
Pre-Launch
Merck & Co.
TOPICAL · DISC
NDA
DISOMER
dexbrompheniramine maleate
Pre-Launch
Merck & Co.
ORAL · SYRUP
nasal congestion due to the common coldhay fever+6
NDA
DISOPHROL
dexbrompheniramine maleate; pseudoephedrine sulfate
Pre-Launch
Merck & Co.
ORAL · TABLET
nasal congestion due to the common coldhay fever+6
NDA
DIUTENSEN-R
methyclothiazide; reserpine
Pre-Launch
Bausch Health
ORAL · TABLET
NDA
DIZAC
diazepam
Pre-Launch
Pfizer
INJECTION · INJECTABLE
epilepsy
NDA
DOLUTEGRAVIR
dolutegravir
Pre-Launch
ORAL · FILM
HIV-1 infection in adultsweighing at least 6 kg
SMNDA
DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE
dolutegravir lamivudine tenofovir alafenamide
Pre-Launch
Cipla
TABLET
NDA
DOLUTEGRAVIR SODIUM
dolutegravir sodium
Pre-Launch
ORAL SUSPENSION · TABLET
HIV-1 infection in adultsweighing at least 6 kg
NDA
DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE
dolutegravir, emtricitabine and tenofovir alafenamide
Pre-Launch
ORAL · TABLET
NDA
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
dolutegravir; lamivudine; tenofovir disoproxil fumarate
Pre-Launch
Inpharmus
ORAL · TABLET
HIV-1 infection in adultsweighing at least 6 kg
NDA
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
dolutegravir; lamivudine; tenofovir disoproxil fumarate
Pre-Launch
Shanghai Sunway Biotech
ORAL · TABLET
HIV-1 infection in adultsweighing at least 6 kg
NDA
DOLUTEGRAVIR, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE
dolutegravir; lamivudine; tenofovir disoproxil fumarate
Pre-Launch
Viatris (2)
ORAL · TABLET
HIV-1 infection in adultsweighing at least 6 kg
NDA
DOLUTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE
dolutegravir; emtricitabine; tenofovir alafenamide
Pre-Launch
ORAL · TABLET
NDA
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
dolutegravir; lamivudine; tenofovir disoproxil fumarate
Pre-Launch
ORAL · TABLET
NDA
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
dolutegravir; lamivudine; tenofovir disoproxil fumarate
Pre-Launch
ORAL · TABLET
NDA
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
dolutegravir; lamivudine; tenofovir disoproxil fumarate
Pre-Launch
ORAL · TABLET
NDA